The store will not work correctly when cookies are disabled.
8-Amino-6-(3,4,5-trimethoxyphenyl)-2-phenyl-1,2,4-triazolo[4,3-a]pyrazin-3(2H)-one
ID: ALA4482881
PubChem CID: 155540525
Max Phase: Preclinical
Molecular Formula: C20H19N5O4
Molecular Weight: 393.40
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(-c2cn3c(=O)n(-c4ccccc4)nc3c(N)n2)cc(OC)c1OC
Standard InChI: InChI=1S/C20H19N5O4/c1-27-15-9-12(10-16(28-2)17(15)29-3)14-11-24-19(18(21)22-14)23-25(20(24)26)13-7-5-4-6-8-13/h4-11H,1-3H3,(H2,21,22)
Standard InChI Key: ZVNUQVQHRWHRQA-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
5.2856 -10.5574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2844 -11.3769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9925 -11.7859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9907 -10.1486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6993 -10.5538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6996 -11.3724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4782 -11.6252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9592 -10.9627 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4778 -10.3007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7733 -10.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1815 -11.6728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9979 -11.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4071 -10.9645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9938 -10.2546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1788 -10.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7310 -12.4023 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9882 -9.3314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5783 -11.7853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8706 -11.3744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1631 -11.7818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1620 -12.5998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8743 -13.0088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5790 -12.5991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8766 -13.8260 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1700 -14.2365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4545 -13.0088 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7466 -12.6006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4559 -11.3723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4569 -10.5551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
7 16 2 0
4 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
2 18 1 0
22 24 1 0
24 25 1 0
21 26 1 0
26 27 1 0
20 28 1 0
28 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.40 | Molecular Weight (Monoisotopic): 393.1437 | AlogP: 2.16 | #Rotatable Bonds: 5 |
Polar Surface Area: 105.90 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.92 | CX LogP: 2.00 | CX LogD: 1.88 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.55 | Np Likeness Score: -0.78 |
References
1. Falsini M, Catarzi D, Varano F, Ceni C, Dal Ben D, Marucci G, Buccioni M, Volpini R, Di Cesare Mannelli L, Lucarini E, Ghelardini C, Bartolucci G, Menicatti M, Colotta V.. (2019) Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain., 62 (18): [PMID:31453698] [10.1021/acs.jmedchem.9b00778] |